Literature DB >> 14980809

Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus.

Liat Ayalon1, Ravid Doron, Ina Weiner, Daphna Joel.   

Abstract

Four groups of rats, sustaining a striatal quinolinic acid (QA) lesion, a pallidal QA lesion, a combined striatal + pallidal lesion, or sham operation, were tested in spontaneous and amphetamine-induced activity, spatial navigation in a water maze, position discrimination and reversal in a wet T maze, and food manipulation. The striatal lesion markedly impaired rats' performance on the motor and cognitive tasks. In contrast, rats sustaining a bilateral lesion to the GP in addition to the striatal lesion performed similarly to sham-operated rats on the motor and cognitive tasks, although they showed a transient decrease in activity levels. Given that a similar dysfunction of basal ganglia circuitry is thought to subserve the behavioral alterations seen in QA-lesioned rats and Huntington's disease (HD) patients, the present results raise the possibility that manipulations of the external segment of the globus pallidus (the primate analogue of the rat GP) could ameliorate some of HD symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980809     DOI: 10.1016/S0014-4886(03)00312-1

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Authors:  Lior Brimberg; Itai Benhar; Adita Mascaro-Blanco; Kathy Alvarez; Dafna Lotan; Christine Winter; Julia Klein; Allon E Moses; Finn E Somnier; James F Leckman; Susan E Swedo; Madeleine W Cunningham; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

2.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

3.  Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Authors:  Dafna Lotan; Itai Benhar; Kathy Alvarez; Adita Mascaro-Blanco; Lior Brimberg; Dan Frenkel; Madeleine W Cunningham; Daphna Joel
Journal:  Brain Behav Immun       Date:  2014-02-20       Impact factor: 7.217

4.  Motor sequences and the basal ganglia: kinematics, not habits.

Authors:  Michel Desmurget; Robert S Turner
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

Review 5.  The corticostriatal pathway in Huntington's disease.

Authors:  Carlos Cepeda; Nanping Wu; Véronique M André; Damian M Cummings; Michael S Levine
Journal:  Prog Neurobiol       Date:  2006-12-13       Impact factor: 11.685

Review 6.  Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety.

Authors:  Lars Wojtecki; Stefan Jun Groiss; Christian Johannes Hartmann; Saskia Elben; Sonja Omlor; Alfons Schnitzler; Jan Vesper
Journal:  Brain Sci       Date:  2016-08-30

7.  Optogenetic Stimulation of GABAergic Neurons in the Globus Pallidus Produces Hyperkinesia.

Authors:  Jun Tian; Yaping Yan; Wang Xi; Rui Zhou; Huifang Lou; Shumin Duan; Jiang Fan Chen; Baorong Zhang
Journal:  Front Behav Neurosci       Date:  2018-08-27       Impact factor: 3.558

8.  Group A streptococcal antigen exposed rat model to investigate neurobehavioral and cardiac complications associated with post-streptococcal autoimmune sequelae.

Authors:  Rukshan A M Rafeek; Catherine M Lobbe; Ethan C Wilkinson; Adam S Hamlin; Nicholas M Andronicos; David J McMillan; Kadaba S Sriprakash; Natkunam Ketheesan
Journal:  Animal Model Exp Med       Date:  2021-04-08

9.  Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.

Authors:  Stéphanie Bissonnette; Mylène Vaillancourt; Sébastien S Hébert; Guy Drolet; Pershia Samadi
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 10.  Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Authors:  Kyle D Fink; Peter Deng; Audrey Torrest; Heather Stewart; Kari Pollock; William Gruenloh; Geralyn Annett; Teresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.